Showing results (11-20 of 2,363) with videos related to
Sort By:
Pageof 237
Alimentary Pharmacology & Therapeutics|January 16, 2004
Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factorsG Treiber, M Schwabe, S Ammon, et al.Digestion|January 1, 1991
Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidineS Walker, U Klotz, A Sarem-Aslani, et al.Alimentary Pharmacology & Therapeutics|October 1, 1991
Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal functionG Treiber, U Gladziwa, T H Ittel, et al.Clinical Pharmacokinetics|July 1, 1985
Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acidU KlotzClinical Pharmacokinetics|January 1, 1976
Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implicationsU KlotzKlinische Wochenschrift|September 15, 1978
[Clinical pharmacokinetics of diazepam and its biologically active metabolites (author's transl)]U KlotzInternational Journal of Clinical Pharmacology and Biopharmacy|March 1, 1978
The bioavailability of alpha-acetyldigoxin from Card-Hydergin--a fixed combination of Hydergine and acetyldigoxinU KlotzClinical Pharmacokinetics|April 5, 2000
Pharmacokinetic considerations in the eradication of Helicobacter pyloriU KlotzFortschritte Der Medizin|August 25, 1977
[Important factors determining human distribution and elimination of diazepam]U KlotzArzneimittel-Forschung|February 21, 2012
The pharmacological profile and clinical use of mesalazine (5-aminosalicylic acid)U KlotzPageof 237